Pneumoconiosis natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 16: | Line 16: | ||
===Natural History=== | ===Natural History=== | ||
*The symptoms of | *The symptoms of pneumoconiosis typically develop ___ years after exposure to ___. | ||
*If left untreated, [#]% of patients with pneumconiosis may progress to develop pulmonary fibrosis and respiratory failure. | |||
*If left untreated, [#]% of patients with | |||
===Complications=== | ===Complications=== | ||
*Common complications of | *Common complications of pneumoconiosis include: <ref name="pmid10741774">{{cite journal| author=Fujimura N| title=Pathology and pathophysiology of pneumoconiosis. | journal=Curr Opin Pulm Med | year= 2000 | volume= 6 | issue= 2 | pages= 140-4 | pmid=10741774 | doi=10.1097/00063198-200003000-00010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10741774 }} </ref> <ref name="pmid16418244">{{cite journal| author=Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS| title=Pneumoconiosis: comparison of imaging and pathologic findings. | journal=Radiographics | year= 2006 | volume= 26 | issue= 1 | pages= 59-77 | pmid=16418244 | doi=10.1148/rg.261055070 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16418244 }} </ref> <ref name="pmid23708110">{{cite journal| author=Cullinan P, Reid P| title=Pneumoconiosis. | journal=Prim Care Respir J | year= 2013 | volume= 22 | issue= 2 | pages= 249-52 | pmid=23708110 | doi=10.4104/pcrj.2013.00055 | pmc=6442808 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23708110 }} </ref> | ||
** | **Pulmonary fibrosis | ||
** | **Emphysema | ||
** | **COPD | ||
**Pleural effusion | |||
**Pleural plaques | |||
**Malignant Mesothelioma (Asbestosis) | |||
**Carcinoma | |||
**Tuberculosis | |||
**Scleroderma | |||
**SLE | |||
**Glomerulonephritis | |||
**Pulmonary hypertension | |||
**Cor pulmonale | |||
**Respiratory failure | |||
===Prognosis=== | ===Prognosis=== | ||
Line 32: | Line 43: | ||
*[Subtype of disease/malignancy] is associated with the most favorable prognosis. | *[Subtype of disease/malignancy] is associated with the most favorable prognosis. | ||
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis. | *The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis. | ||
*The prognosis for pneumoconiosis is poor and leads to respiratory complications and premature death. | |||
<ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=32310362 | doi= | pmc= | url= }} </ref> | |||
==References== | ==References== |
Revision as of 17:18, 29 April 2021
Pneumoconiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumoconiosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Pneumoconiosis natural history, complications and prognosis |
FDA on Pneumoconiosis natural history, complications and prognosis |
CDC on Pneumoconiosis natural history, complications and prognosis |
Pneumoconiosis natural history, complications and prognosis in the news |
Blogs on Pneumoconiosis natural history, complications and prognosis |
Risk calculators and risk factors for Pneumoconiosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of pneumoconiosis typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with pneumconiosis may progress to develop pulmonary fibrosis and respiratory failure.
Complications
- Common complications of pneumoconiosis include: [1] [2] [3]
- Pulmonary fibrosis
- Emphysema
- COPD
- Pleural effusion
- Pleural plaques
- Malignant Mesothelioma (Asbestosis)
- Carcinoma
- Tuberculosis
- Scleroderma
- SLE
- Glomerulonephritis
- Pulmonary hypertension
- Cor pulmonale
- Respiratory failure
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
- The prognosis for pneumoconiosis is poor and leads to respiratory complications and premature death.
References
- ↑ Fujimura N (2000). "Pathology and pathophysiology of pneumoconiosis". Curr Opin Pulm Med. 6 (2): 140–4. doi:10.1097/00063198-200003000-00010. PMID 10741774.
- ↑ Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS (2006). "Pneumoconiosis: comparison of imaging and pathologic findings". Radiographics. 26 (1): 59–77. doi:10.1148/rg.261055070. PMID 16418244.
- ↑ Cullinan P, Reid P (2013). "Pneumoconiosis". Prim Care Respir J. 22 (2): 249–52. doi:10.4104/pcrj.2013.00055. PMC 6442808. PMID 23708110.
- ↑ "StatPearls". 2021. PMID 32310362 Check
|pmid=
value (help).